Breast Disorders Flashcards

1
Q

breast examination

A
  • Clinical breast exam
    • American Cancer Society: evidence unclear, no recommendations; “be familiar”
    • NCCN recommends CBE every 1-3 years age 25-39 and yearly at age 40
    • US Preventive Services Task Force: not enough evidence
  • Self breast exam
    • Good to have self-awareness
    • May discover lumps earlier than screening
    • May not be reliable and can lead to additional tests and biopsies
  • Clinical cancers may not be seen with screening
  • Physical exam includes: chest, neck, axilla, breast
  • Part of your physical exam but self breast exam not recommended anymore.
  • The US Preventive Services Task Force concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination beyond screening . They recommend against clinicians teaching women how to perform breast self- examination. mammography in women 40 years and older= what does this mean? Recommend breast exams to younger and older women (who are not screened with mammo)
  • Encourage “breast self awareness”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

breast disorders

A
  • Fibrocystic breast changes
    • Hormonal changes
    • Lumpiness, cysts, pain, nipple secretions
    • Tx: support, minimize caffeine & salt, daily exercise, low fat diet, Vit E 100 IUs daily or Vit B6 100 mg daily, Evening primrose oil capsules 1000-3000 mg qd or other omega-3s, NSAIDs, moist heat
  • Accessory breast tissue
  • Fibrocystic changes is not a disease. Just a description of breast changes that can cause pain, lumps, swelling , cysts.
  • If a symptomatic simple breast cyst recurs several times after aspiration, another mammogram and ultrasound should be performed to evaluate the area again. Excision is reserved for suspicious lesions or for patients who no longer desire repeat aspirations.
  • Complicated cysts are rarely malignant, but should be aspirated to confirm diagnosis or followed with imaging and examination every six months for two years to document stability. Image-guided FNA or biopsy is indicated if the lesion increases in size or changes in characteristics on repeat imaging.
  • Complex cysts should be biopsied, particularly those with thickened cyst walls and/or septa, and solid components.
  • Surgical intervention is indicated for complex cysts that are not amenable to core needle biopsy and when pathology results from a core biopsy are discordant, atypical, indeterminate, or reveal a malignancy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

benign breast lumps

A
  • A fibroadenoma is a firm, noncancerous tumor of a gland, often found in the breast during a breast self-exam. It is round, painless, feels firm and rubbery, and can be easily moved around.
  • Fibroadenomas may occur as one lump or multiple lumps in the breast. They are most common in women in their late teens and early 20s. Fibroadenomas can be stimulated by estrogen and progesterone. Breast imaging can suggest a fibroadenoma however diagnosis must be done by biopsy since they can resemble cancer. Once diagnosed, removal is not necessary. Sometimes they stop growing or shrink on their own without treatment.
  • Breast cyst:
  • A smooth, easily movable round or oval breast lump with distinct edges. Usually found in one breast, but can affect both breasts at the same time
  • Breast pain or tenderness in the area of the breast lump
  • Increase in breast lump size and breast tenderness just before your period
  • Decrease in breast lump size and resolution of other signs and symptoms after your period
  • Having one or many simple breast cysts doesn’t increase your risk of breast cancer. But having cysts may interfere with your ability to detect new breast lumps or other abnormal changes. Diagnosis can by done by mammogram or ultrasound, aspiration can be done for diagnosis and treatment. Recurrence is common
  • Vit E, B6 can relieve pain associated with cysts. Caffeine reduction can reduce prevalence.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

biopsies

A
  • Fine needle aspiration: cellular sample
  • Core biopsy: tissue sample
  • Excisional biopsy: larger sample
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

nipple discharge - benign

A
  • Very common
  • Physiologic (benign) vs pathologic
  • Benign nipple discharge is usually bilateral, multi-ductal, and occurs with breast manipulation.
  • Risk of cancer is higher when the discharge is spontaneous, bloody or guaiac positive, unilateral/uni-ductal associated with a breast mass, or occurs in a woman over 40 years of age
  • One of the most commonly encountered breast complaints- mostly benign in origin
  • Up to 50-80% of women in their reproductive years can express one or more drops of fluid
  • Benign nipple discharge is usually bilateral, multi-ductal, and occurs with breast manipulation.
  • Risk of cancer is higher when the discharge is spontaneous, bloody or guaiac positive, unilateral/uni-ductal associated with a breast mass, or occurs in a woman over 40 years of age.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

physical exam of nipple discharge

A
  • Physiologic (benign) vs pathologic
    • Intraductal carcinoma
    • Papilloma
    • FBC/duct ectasia
    • Prolactinoma
    • Pregnancy
    • Hypothyroid
    • Medications
  • Complete medical history:
    • Medication
    • Lactation status
    • Appearance of the discharge
    • Spontaneous or provoked by manipulation of the breast
    • Unilateral or bilateral
    • bilateral nipple discharge is usually due to an endocrinologic or physiologic process, although bilateral synchronous cancers can occur.
  • Recent trauma
    • Mammographic imaging with compression as well as vigorous manipulation of the nipple by the patient or her partner.
  • Recent onset of amenorrhea or other symptoms of hypo-gonadism
    • Hot flashes, vaginal dryness, etc.
    • consider hyper-prolactinemia
  • Exam
    • Try to elicit discharge from a nipple and identify the involved duct or ducts
    • Pressure in a clockwise fashion around the areola can identify a specific site or duct
    • If unclear if blood in discharge, can use sterile white gauze or can send discharge down to path on a dry slide.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clear/colored/milky nipple discharge labs and imaging

A
  • Labs
  • Multiductal discharge and/or symptoms (such as menstrual irregularity, infertility, headaches, visual disturbances, or symptoms of hypothyroidism)
    • HCG quant, prolactin, Creatinine/BUN, TSH
    • *appropriate endocrinological follow-up if there are abnormal findings
  • Uniductual discharge:
    • no testing indicated
  • Imaging
    • Age appropriate screening if no palpable lesion.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

causes of clear/colored/milky nipple discharge

A
  • Causes:
    • Abscess
    • Breast cancer
    • Breast infection
    • Excessive breast stimulation
    • Fibroadenoma
    • Fibrocystic breasts
    • Ductal carcinoma in situ (DCIS)
    • Galactorrhea
    • Hormone imbalance
    • Injury or trauma to the breast
    • Intraductal papilloma
    • Mammary duct ectasia
    • Medication use
    • Paget’s disease of the breast
    • Pregnancy
    • Prolactinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

causes of galactorrhea

A
  • Medications, such as certain sedatives, antidepressants, antipsychotics and high blood pressure drugs
  • Cocaine or opioid use
  • Herbal supplements, such as fennel, anise or fenugreek seed
  • Birth control pills
  • Noncancerous pituitary tumor (prolactinoma) or other disorder of the pituitary gland
  • Underactive thyroid (hypothyroidism)
  • Chronic kidney disease
  • Excessive breast stimulation, which may be associated with sexual activity, frequent breast self-exams with nipple manipulation, a skin rash on the chest or prolonged clothing friction
  • Idiopathic galactorrhea, may just mean that your breast tissue is particularly sensitive to the milk-producing hormone prolactin in your blood. Increased sensitivity to prolactin, even with normal prolactin levels can lead to galactorrhea.
  • Galactorrhea in men
    • In males, galactorrhea may be associated with testosterone deficiency (male hypogonadism) and usually occurs with breast enlargement or tenderness (gynecomastia). Erectile dysfunction and a lack of sexual desire also are associated with testosterone deficiency.
  • Galactorrhea in newborns
    • Galactorrhea sometimes occurs in newborns. High maternal estrogen levels cross the placenta into the baby’s blood. This can cause enlargement of the baby’s breast tissue, which may be associated with a milky nipple discharge.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

treatment of clear/colored/milky nipple discharge

A

if persists, can consider central duct excision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bloody nipple discharge labs and imaging

A
  • Bloody Nipple Discharge
    • Grossly bloody nipple discharge simply means that a lesion in the duct is bleeding.
    • Differential diagnosis
    • Intraductal carcinoma (in-situ or invasive)
    • Bleeding papilloma
    • Benign fibrocystic changes with an active intraductal component
    • eg, plasma cell mastitis, ductal ectasia, intraductal hyperplasia, or papillomatosis
    • Pregnancy and lactation (up to 20% of the time)
    • hypervascularity of developing breast tissue, benign, requires no treatment
      • for bilateral, multiductal persistant secretions, think about endocrine causes
    • check serum preg, Prolactin, TSH, Creatinine
  • Imaging
    • >35yo diagnostic mammogram including peri-areolar U/S
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

treatment of bloody nipple discharge

A
  • Treatment
    • If imaging negative and
  • <60yo→ close follow up with exam and imaging vs ctrl duct excision
  • >60yo→ central duct excision
    • If imaging positive, appropriate management with biopsy/surgical referral.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

nipple discharge

A
  • Labs: Serum prolactin, pregnancy test, TSH, BMP (renal function)
  • Imaging: retroareolar ultrasound and mammography
    • Ductography, breast MRI, magnetic resonance ductography, and ductoscopy can be helpful in selected women but are not routinely necessary
  • Surgical evaluation of pathologic nipple discharge with central duct excision is required for diagnosis and treatment even if the imaging results are negative
    • You make a small cut around the nipple and send a biopsy off to pathology
  • Treat underlying cause, discontinue offending medication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

breast pain (mastalgia)

A
  • Obtain a good history!
  • Cyclical, localized area, trauma/injury, diet/weight changes
  • Workup-imaging not typically needed
  • Treatment/Counseling: reassurance!
    Support garments, NSAIDs/Tylenol, Low fat diet, less caffeine, OCPs
  • It may come and go with monthly periods (cyclic) or may not follow any pattern (noncyclic).
  • Cyclic pain is the most common type of breast pain. It may be caused by the normal monthly changes in hormones. This pain usually occurs in both breasts. It is generally described as a heaviness or soreness that radiates to the armpit and arm. The pain is usually most severe before a menstrual period and is often relieved when a period ends. Cyclic breast pain occurs more often in younger women. Most cyclic pain goes away without treatment and usually disappears at menopause.
  • Noncyclic pain is most common in women 30 to 50 years of age. It may occur in only one breast. It is often described as a sharp, burning pain that occurs in one area of a breast. Occasionally, noncyclic pain may be caused by a fibroadenoma or a cyst. If the cause of noncyclic pain can be found, treating the cause may relieve the pain.
  • Breast pain can get worse with changes in your hormone levels or changes in the medicines you are taking. Stress can also affect breast pain. You are more likely to have breast pain before menopause than after menopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mastitis

A
  • Breast infection, often as a result from breastfeeding/clogged ducts. Spontaneous cases too, especially in smokers; can be chronic
  • Systemic symptoms feels like the flu
    • Red, hot swollen breast +/- abscess
  • No imaging necessary if clinically suspect
  • infection and complete resolution
  • tx: antibiotics (Keflex, Duricef, dicloxacillin (breastfeeding), Bactrim, Clindamycin), breast feeding technique, hot compresses, I&D/aspiration for abscesses, rarely surgery
  • imaging +/- biopsy if no improvement
  • For women that are breast feeding, you want to avoid I and Ds because they can get milk fistulas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

other infections of the breast

A
  • fungal (candida)
  • hidradenitis – they are kind of like cysts – armpits, bikini line, etc.
    • more common in women
    • lifelong battle with these chronic infections
    • sometimes you need abx, I and D, etc.
    • women that are heavier and overweight as well as smokers are more prone to these
  • infected sebaceous cyst
17
Q

gynecomastia

A
  • benign proliferation of the glandular tissue of the male breast
  • caused by an increase in the ratio of estrogen to androgen activity
  • may be unilateral or bilateral
  • causes: drugs, medications, hyperthyroidism, liver or kidney disease, hypogonadism, testicular tumors, aging
  • diagnosed on exam as a palpable mass of tissue at least 0.5 cm in diameter (usually underlying the nipple)
  • labs: estradiol, testosterone, LH, FSH, prolactin, TSH, HCG
    • youre getting HCG because testicular cancer can produce HCG
  • ddx: pseudogynecomastia
  • Treatment:
    • plastic surgery if significant/bothersome
    • lifestyle modifications
18
Q

breast cancer

A
  • 1 in 8 women will develop breast cancer in their lives
  • Average lifetime risk 12%; most common cause of cancer in women
  • 2nd leading cause of cancer death, following lung cancer
  • Good news! Breast cancer mortality has been decreasing since 1990 largely due to mammography screening and improved treatment
  • Breast cancer facts
    • 2nd leading cause of cancer death among women in the United States. – Mortality rates have decreased 34% due to early detection and advances in treatment.
    • Female breast cancer is most common in middle-aged and older women. Although rare, men can develop breast cancer as well. The number of new cases of breast cancer was 124.8 per 100,000 women per year based on 2008-2012 cases.
  • Cancer is a group of disease that cause cells in the body to change and grow out of control. Most types of cancer cells eventually form a lump or mass called at tumor.
  • Invasive/Infiltrating
  • In-situ “pre-cancer” – not in the form of a tumor or mass
  • Inflammatory – the breast tissue gets really heavy and hot
  • Paget’s disease
  • Invasive breast cancer has grown through the lobules or ducts and has potential to spread through the lymphatic system to other areas of the body.
  • In-situ cancer is contained within the ducts or lobules.
  • Currently ductal carcinoma in-situ is treated so that it does not progress to invasive cancer. Should we call it cancer? Are we over treating people?
  • Risk factors: radiation exposure obesity increases risk of postmenopausal breast cancer due to estrogen production from fatty tissue
    • more menstrual cycles- increased risk due to longer lifetime exposure to reproductive hormones.
  • Breast feeding for a year or more decreases risk of breast cancer
  • There is no conclusive evidence that diet influences breast cancer risk.
19
Q

risk factors for breast cancer

A
  • radiation exposure
  • obesity (postmenopausal)
  • early menarche, late menopause
  • late or no pregnancy
  • smoking
  • alcohol
  • HRT/OCPs
  • family history/genetic mutations (BRCA, CHEK2)
  • previous breast cancer or high risk lesions
    • ADH, ALH, LCIS
  • protective: breast feeding, multiple parity
20
Q

mammogram

A
  • Majority of breast cancers diagnosed by abnormal mammogram–show as a spiculated soft tissue mass with architectural distortion, or pleomorphic microcalcifications in a ductal distribution (DCIS)
  • Most mammogram abnormalities are from benign disease
  • Will get “diagnostic” mammogram and add ultrasound for findings on screening mammogram to further characterize finding
  • Controversial of when to start routine screening mammograms for average population, between 40-50
21
Q

multiple screening guidelines

A
  • American cancer society recommends annual mammogram starting at age 45 -55 yo, then can be every 2 years. can start at 40
  • The USPSTF recommends against routine screening mammography in women aged 40-49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take into account patient risk factors (fhx of breast cancer, history of breast biopsy etc)
  • Digital better for dense breasts and women <50 yo
  • Benefit of screening depends on age. Screening between 50-69 years produced a projected 17% reduction in mortality
  • Harms- false positive, over diagnosis and treatment of potentially non-life threatening disease
  • Low radiation exposure
  • Tomosynthesis similar to a CT scan takes several xrays through the breast creating a “3D” picture. Combined with standard mammogram can increase detection rates and decrease false positive. Not reimbursed by most insurances, expensive, higher radiation exposure. May be a good adjuvant for very dense breast tissue.
22
Q

additional breast imaging

A
  • MRI for high risk >20% lifetime risk
  • Ultrasound
  • Tomosynthesis (3D Mammo)
    • Reconstructed images similar to CT
    • Improves detection of masses (not calcs) in dense tissue, lower false +
    • 1.5-2x more radiation vs. digital mammo, longer interpretation time
  • Breast MRI:
  • No role in screening for the average risk patient, Higher rate of false positives
  • Indications for MRI for screening
    • BRCA 1 or 2 gene mutation
    • First degree relative with BRCA 1 or 2
    • Increased lifetime risk
    • History of mammographicall occult breast cancer
    • Radiation therapy to the chest wall young age
  • Breast ultrasound- used for diagnostic workup in combination with mammogram. Not used for surveillance.
  • Thermography-measures heat. Procedure is safe but does not detect or provide a diagnosis of any condition. Currently not endorsed by any reputable medical agency including the american cancer society, national cancer institiute, american college of radiology, american medical association
23
Q

breast MRI

A
  • Benefit: No radiation, very sensitive
  • Risks: IV contrast (kidneys), lower specificity, inferior to mammo for calcs, cost, time, metal, claustrophobia
  • The American Cancer Society’s recommendations for MRI screening:
      1. Lifetime risk of breast cancer >20%
        * based on risk assessment models (BRCAPRO, GAIL, IBIS)
        * personal genetic mutation (BRCA ½, Li Fraumeni, Cowden) or 1st degree relative with one.
      1. Hx radiation treatment to the chest prior to age 30 yo
  • *Considerations for surgical planning of invasive lobular carcinoma, screening for women with h/o mammographically occult cancers, extremely dense breast tissue + risk factors
  • Breast MRI is an imaging technique used for certain women at very high risk for cancer. MRI isn’t recommended for screening for most women because it is too sensitive to normal glandular, ‘fibrocystic’ breast changes. When used, it should be used in addition to mammogram since it can miss certain early cancers that are seen easily on mammogram.
24
Q
A
25
Q

invasive (infiltrative) breast cancer

A
  • Ductal origin vs. Lobular origin
    • Exam: mass, nipple/skin changes
    • bloody nipple discharge, lymphadenopathy
    • Imaging: mammo/uls
    • Diagnosis- biopsy
  • Estrogen and progesterone receptor status, Her2neu
26
Q

ductal carcinoma in-situ (DCIS)

A
  • Precursor to invasive cancer in half of cases.
  • Higher detection
  • Abnormal number and morphology of cells lining the duct, not extending into the breast tissue.
  • Appears as new pleomorphic calcifications or linear branching. Not usually palpable
  • Higher diagnosis since improvement in mammogram quality
  • Treated like cancer, - surgery, radiation and endocrine treatment
  • Not life threatening- we treat it so it does not progress to invasive cancer. Some DCIS may never progress, but which ones?
  • Genetic profile testing on the horizon to identify which DCIS should be treated
27
Q

inflammatory breast cancer

A
  • Inflammatory breast cancer is a rare type of breast cancer that develops rapidly, making the affected breast red, swollen and tender.
  • Inflammatory breast cancer occurs when cancer cells block the lymphatic vessels in skin covering the breast, causing the characteristic red, swollen appearance of the breast.
  • It is considered a locally advanced cancer — meaning it has spread from its point of origin to nearby tissue and possibly to nearby lymph nodes.
  • include:
  • Rapid change in the appearance of one breast, over the course of several weeks
  • Thickness, heaviness or visible enlargement of one breast
  • Discoloration, giving the breast a red, purple, pink or bruised appearance
  • Unusual warmth of the affected breast
  • Dimpling or ridges on the skin of the affected breast, similar to an orange peel
  • Tenderness, pain or aching
  • Enlarged lymph nodes under the arm, above the collarbone or below the collarbone
  • Flattening or turning inward of the nipple
  • Inflammatory breast cancer doesn’t commonly form a lump, as occurs with other forms of breast cancer
  • Workup- diagnostic mammogram, punch biopsy of skin and core biopsy if mass evident
  • Treatment usually involves chemotherapy first, then mastectomy and systemic treatment.
28
Q

Paget’s disease

A
  • looks like eczema of the nipple – suspect if it doesn’t go away
    • Mammary Paget’s disease (MPD) is almost always associated with an underlying breast cancer in 92-100% of cases. [11],[12] Approximately 50% of this patients present with an associated mass.
    • Figure 1: (a and b) Paget’s disease of the nipple. The clinical appearance is usually a thickened, eczematoid crusted lesion with irregular borders. (c) Scaly, erythematous, crusty pigmentation and thickened plaques on the nipple, spreading to the surrounding areolar areas. (d) Advanced lesions show skin thickening, redness, erythema, erosion of the nipple and scaling around the nipple-areola
      Treatment: surgery , radiation and/or chemo/endocrine therapy
29
Q

treatment of breast cancer

A
  • Surgery, Radiation
    • Surgery- Lumpectomy with radiation therapy vs. Mastectomy +/- reconstruction
    • Axillary sentinel lymph node biopsy vs. dissection
    • Surgery to remove the tumor, axillary node biopsy for staging and prognostic information.
    • Lymph node dissection is done for biopsy proven cancer in the lymph nodes.
    • Radiation offers local control to help reduce recurrence rate.
    • Treatment is usually 5 days a week for 5 weeks, starts 1 month after surgery or chemotherapy
30
Q

prognostic factors of breast cancer

A
  • We have hormone treatment that reduces the estrogen
  • Her2neu – gene that used to indicate a very vast, aggressive type of cancer
    • However, we not have a tx that is very effective
  • Triple negative is the most aggressive type of cancer – higher incidence of recurrence and spread
31
Q

systemic treatment of breast cancer

A
  • Chemotherapy – Neo-adjuvant or Adjuvant
  • Oncotype score
  • Endocrine therapy- ER+ tumors only
  • Herceptin- Her2neu + tumors only
  • Chemotherapy systemic protection from cancer spread and reduction for recurrence. Not offered to everyone
  • Neoadjuvant chemo to down stage for metastatic disease ( & inflammatory BC) or to shrink a breast tumor to provide option for breast conservation surgery
  • Oncotype score- tissue tested for 21 genes that can influence how likely a cancer is to grow and respond to treatment.
  • Determines a woman’s risk of early-stage (1 or 2), estrogen-receptor-positive breast cancer from coming back (recurrence), as well as how likely she is to benefit from chemotherapy after breast cancer surgery
  • Endocrine treatment for estrogen receptor positive tumors only. Reduces circulating estrogen
  • Specific Medication depends on menopausal status. Most recommend taking for 5-10 years. Low adherence rate due to side effects (hot flashes, mood swings, insomnia, muscle and joint pain)